Loading company…
SZ Inhal develops inhaled pharmaceutical formulations and delivery devices.
SZ Inhal is a pharmaceutical company based in Suzhou, China, that develops inhaled preparations and delivery devices. Its products include dry powder formulations and reservoir, blister, capsule, and disposable inhalers for small molecules, peptides, and biological macromolecules. The company raised CNY 50 million in Series A funding in October 2023 and approximately CNY 50 million in Series A+ funding in June 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in